OMADA HEALTH ($OMDA) Releases Q1 2026 Earnings, Stock Rises

OMADA HEALTH ($OMDA) announced its Q1 2026 earnings, reporting $0.01 per share against an estimated loss of -$0.08, and revenue of $78.05 million, surpassing estimates by over $2.5 million. Following the report, the company's stock price increased by 9.15%. The article also details significant insider selling activity, mixed hedge fund movements with both additions and reductions, and recent analyst ratings with a median price target of $20.0.

Original reporting
Quiver Quantitative · Quiver EarningsTracker
Published May 8, 2026, 4:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 8, 2026, 5:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
OMADA HEALTH ($OMDA) Releases Q1 2026 Earnings, Stock Rises — source image
Decision brief

The 30-second read

$OMDABullishHigh
01

Why it matters

The earnings beat has positively influenced investor sentiment and stock price, potentially signaling a bullish trend in the near term.

02

Market read

The company's strong quarterly performance enhances its market position, with implications for health tech investors.

03

What to watch

Insider selling activity and mixed hedge fund movements suggest caution; these could indicate upcoming volatility or profit-taking.

Timing: immediate, given the recent earnings release and stock price response.

Background

OMADA HEALTH's Q1 2026 earnings exceeded expectations, demonstrating operational strength amid industry competition.

Company-level read

Ticker impact

$OMDABullishHigh confidence
Context

Primary focus due to recent earnings report and stock movement.

Expected impact

Moderate upward movement in the near term, with potential for continued gains if earnings momentum persists.

Evidence & confidence

Strong earnings beat against estimates, coupled with positive market reaction, indicates robust financial performance. The stock's recent rise and positive sentiment support a bullish outlook in the short term.

Market effects

The positive earnings report may bolster investor confidence in the health tech sector, potentially leading to sector-wide gains.

Limited, as OMADA HEALTH primarily operates domestically, with minimal immediate regional influence.

Moderate, as health tech is a growing industry segment, but OMDA's size limits broader global impact.

Counterpoint

The strong earnings report may already be priced in, and the stock could experience a short-term pullback or consolidation.

Key entities

  • OMADA HEALTH

    A health technology company specializing in digital health solutions.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.